1. Home
  2. CC vs SYRE Comparison

CC vs SYRE Comparison

Compare CC & SYRE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Chemours Company (The)

CC

Chemours Company (The)

HOLD

Current Price

$17.04

Market Cap

2.3B

Sector

Industrials

ML Signal

HOLD

Logo Spyre Therapeutics Inc.

SYRE

Spyre Therapeutics Inc.

HOLD

Current Price

$43.21

Market Cap

2.6B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
CC
SYRE
Founded
2014
2013
Country
United States
United States
Employees
N/A
N/A
Industry
Major Chemicals
Biotechnology: Pharmaceutical Preparations
Sector
Industrials
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
2.3B
2.6B
IPO Year
2014
2015

Fundamental Metrics

Financial Performance
Metric
CC
SYRE
Price
$17.04
$43.21
Analyst Decision
Buy
Strong Buy
Analyst Count
8
6
Target Price
$16.13
$56.50
AVG Volume (30 Days)
3.2M
573.5K
Earning Date
05-24-2026
05-19-2026
Dividend Yield
1.72%
N/A
EPS Growth
N/A
N/A
EPS
N/A
N/A
Revenue
$6,638,000,000.00
N/A
Revenue This Year
$3.34
N/A
Revenue Next Year
$4.03
N/A
P/E Ratio
N/A
N/A
Revenue Growth
7.36
N/A
52 Week Low
$9.13
$10.91
52 Week High
$21.85
$38.16

Technical Indicators

Market Signals
Indicator
CC
SYRE
Relative Strength Index (RSI) 50.19 72.37
Support Level $19.65 $34.96
Resistance Level $21.43 $37.98
Average True Range (ATR) 1.37 2.11
MACD -0.03 0.56
Stochastic Oscillator 40.00 98.33

Price Performance

Historical Comparison
CC
SYRE

About CC Chemours Company (The)

The Chemours Co is a provider of chemicals. It delivers customized solutions with a wide range of industrial and specialty chemicals products for various markets including coatings, plastics, refrigeration, air conditioning, etc. The company's operating segments include Titanium Technologies, Thermal & Specialized Solutions, and Advanced Performance Materials. It generates maximum revenue from the Titanium Technologies segment. The Titanium Technologies segment is a producer of TiO2 pigment, a premium white pigment used to deliver whiteness, brightness, opacity, durability, efficiency, and protection across a variety of applications. Geographically, the company derives a majority of its revenue from North America.

About SYRE Spyre Therapeutics Inc.

Spyre Therapeutics Inc is a biotechnology company that aims to create the next-generation of inflammatory bowel disease (IBD) products by combining antibody engineering, rational therapeutic combinations, and precision medicine approaches for patient selection. IBD is a chronic condition characterized by inflammation within the gastrointestinal tract, including two main disorders which are UC and CD. It has a single reportable segment, which is the development of biopharmaceutical products for the treatment of patients with IBD and other immune-mediated disease.

Share on Social Networks: